News

Survey results emphasize the value of educating full-time students with science- and health care-focused majors about vaccines.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of June 16, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

De-escalation to monotherapy upon bacteremia resolution did not result in unfavorable outcome differences compared with those who continued combination therapy.

Bacteria carrying tandem Guiana extended-spectrum β-lactamase enzymes may be an emerging threat in the United States, a new study suggests.

The FDA has expanded the patient population and issued updated drug interactions, warnings, and precautions for Biktarvy.

A recent animal trial reveals that MK-8591 offers protection against SHIV at lower and more infrequent doses than current PrEP options, renewing hope for more choices in the future.

Kaiser Permanente Northern California’s study shows that the pertussis vaccine weakens as time passes after a patient's most recent vaccination.

From biosensors to travel screening efforts, here's how DHS is beefing up biodefense.

Vibrio vulnificus is a serious gram-negative pathogen that can lead to wound and intestinal infections and has high rates of mortality.

The sNDA application is based on positive results from a Phase III, randomized, double-blind, study that compared the efficacy and safety of BAXDELA to moxifloxacin for the treatment of CABP.

The neighboring nation to the DRC has also launched ring vaccination following the confirmation of 3 travel-associated Ebola cases.

A new study finds that age, sex, and site of infection can increase the risk of long-term mortality in the first 5 years following sepsis survival.

We asked those working on the frontlines to share their thoughts on the scope of the problem and possible solutions.

A phase 1 study demonstrated that pembrolizumab is appropriate for FDA-approved indications and clinical trials among people living with HIV and advanced cancer.

It's time to use data technology to help tackle epidemics and pandemic preparedness.

According to the study, the 3 contraceptive methods that were studied had high levels of safety and effectiveness in preventing pregnancy and well received by study participants.

How can we possibly clean our hands with highly contaminated sinks?

A team of investigators at Washington University School of Medicine used favipiravir to cure Bourbon virus in a mouse model.

Spurred by an increasing population of homeless individuals and a waning vaccination rate, Los Angeles is teetering on the brink of an infectious disease emergency.

A recent study found some improvement in bone density after PrEP discontinuation along with some lingering concerns, particularly among the youngest participants.

Health officials point to substantial progress in flu surveillance, treatment, and prevention; however, the global population remains vulnerable to new emerging viruses.

Develop an exposure plan before a communicable disease event and save yourself time and money.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of June 9, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Research from APIC provides insight into how to strengthen this critical component to patient safety.

Health workers had to act quickly when 30,000 gallons of water spilled into the operating room of a level 1 trauma center in Texas.

The Leptospira genus is much more diverse than previously thought, according to a new analysis.